Home» News&Events» News» PKU Holds Campus Argumentation Meeting for Frontiers Science Center for Cancer Integrative Omics

PKU Holds Campus Argumentation Meeting for Frontiers Science Center for Cancer Integrative Omics

  On April 22, 2022, a campus argumentation meeting for the Frontiers Science Center for Cancer Integrative Omics led by academician Zhan Qimin was held in the Science and Technology Building of Peking University Health Science Center (PKUHSC). An expert group was formed by 10 people, including Yuan Yingjin and Wang Songling, academicians of the Chinese Academy of Sciences, Shen Hongbing, Lin Dongxin, Jiang Jiandong and Xu binghe, academicians of the Chinese Academy of Engineering, Xu Anlong, president of Beijing University of Chinese Medicine, Yu zujun, vice president of Beijing Jiaotong University, Liu Zhihua, vice president of Cancer Hospital of the Chinese Academy of Medical Sciences, and Du Jie, director of the Center for Precision Medicine of Beijing Anzhen Hospital. Academician Shen Hongbing served as the group leader.

  

  Qiao Jie, executive vice president of PKU, president of PKUHSC, and academician of the Chinese Academy of Engineering, pointed at the meeting that she has always attached great importance to the application and construction work of the Frontiers Science Center. Based on the principle of "mature one, build one", the construction and operation work of the innovation bases including the Frontiers Science Center has also been guaranteed by the university’s relevant policy support.

  

  Academician Zhan Qimin reported to the expert group the construction plan of " Frontiers Science Center for Cancer Integrative Omics " and the in-depth cross-disciplinary research carried out from five directions.

  

  The experts present at the meeting fully questioned and discussed the construction plan of the Center, and agreed that the " Frontiers Science Center for Cancer Integrative Omics " is of great significance to enhance China's international competitiveness in the field of life medicine and promote the implementation of the Healthy China strategy. The preliminary work of the Center has a solid foundation, well-defined development goal and reasonable scheme, so the experts all agreed that the center has passed the argumentation. At the same time, the experts also put forward constructive ideas and suggestions on the future development of the Center.

  

  

  Written by: Wu Zhaoxia

  Edited by:Liu Xin

  Source: Office of Scientific Research

TOP